Monthly Archives - March 2020

BluGlass (ASX:BLG) non-renounceable rights issue

31 Mar 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO,Giles Bourne, talks about the company's 1:1 non-renounceable rights issue, the need to fund its technology through to commercialisation, independent validation of its RPCVD technology and its response to COVID-19.


Oil crashes to an 18-year low: ASX poised to open higher

31 Mar 2020 - We saw a surge on the markets yesterday closing 7% higher – this movement is expected to continue with the ASX expected to open higher this morning. European governments moved to tighten restrictions to contain the coronavirus outbreak with an unrelenting rise in infections and deaths. Air New Zealand (ASX:AIZ) will begin reducing its workforce from this week as the severe economic impact of COVID-19 hits the airline.


A great session on the markets jumping up in afternoon trade: ASX closed 7 per cent higher

30 Mar 2020 - It has been a mostly positive day of trade for the ASX after managing to gain momentum the local bourse managed to close 7% higher. Mayne Pharma (ASX:MYX) shares saw a rise today. Cyclopharm, (ASX:CYC) through its subsidary Cyclomedica Australia, has lodged its New Drug Application (NDA) for Technegas, a nuclear medicine functional lung ventilation imaging agent, with the United States Food and Drug Administration (USFDA).